📰 3 sources covering this story

HSE to fund Friedreich's Ataxia drug after improved price but notes 'limited efficacy'

First covered 2 days ago · latest take 1 hrs ago. Compare how each outlet is covering it — and rate the sources you trust.

HSE to fund Friedreich's Ataxia drug after improved price but notes 'limited efficacy'
TheJournal.ie
TheJournal.ie1 hrs ago
HSE to fund Friedreich's Ataxia drug after improved price but notes 'limited efficacy'
The HSE said it ‘took account of a substantially improved financial offer made in recent days by the company Biogen’.
Irish Times
Irish Times2 hrs ago
HSE agrees to fund drug for patients with Friedreich’s ataxia
Omaveloxolone, branded as Skyclarys, has been approved in US and Europe for treatment of disease
RTÉ News
RTÉ News🏁 first to report2 days ago
Friedreich's Ataxia campaigners calling for drug approval
A demonstration has taken place in Dublin city centre calling on the HSE to approve reimbursement for Skyclarys, a drug used to treat Friedreich's Ataxia.
Top rated outlets
Outlets are ranked once they have 3+ community ratings — be one of the first to rate.
🏆 Most trusted sources 2026 →
Scores come entirely from reader ratings — rate the sources you read to shape them. How it works →